Momenta Pharma
(MNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,990 | 84,897 | 85,827 | 56,157 | 66,745 |
| Marketable Securities | 287,613 | 276,921 | 303,984 | 343,604 | 299,193 |
| Receivables | 11,611 | 6,135 | 20,406 | 23,485 | 30,936 |
| TOTAL | $357,167 | $371,906 | $413,051 | $426,318 | $399,421 |
| Non-Current Assets | |||||
| PPE Net | 22,380 | 23,346 | 22,349 | 20,252 | 13,327 |
| Intangibles | 6,711 | 6,976 | 7,241 | 7,507 | 7,772 |
| Other Non-Current Assets | 20,371 | 20,371 | 2,860 | 389 | 389 |
| TOTAL | $49,462 | $50,693 | $32,450 | $28,148 | $21,488 |
| Total Assets | $406,629 | $422,599 | $445,501 | $454,466 | $420,909 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,580 | 6,721 | 3,842 | 9,421 | 4,709 |
| Accrued Expenses | 9,641 | 7,949 | 10,750 | 6,834 | 9,131 |
| Other current liabilities | 514 | N/A | N/A | N/A | 32 |
| TOTAL | $18,161 | $20,194 | $21,086 | $22,625 | $16,028 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,426 | 5,524 | 6,494 | 6,370 | 2,156 |
| Other Non-Current Liabilities | 712 | 51 | 51 | 51 | 195 |
| TOTAL | $27,981 | $27,682 | $28,103 | $29,649 | $1,803 |
| Total Liabilities | $46,142 | $47,876 | $49,189 | $52,274 | $17,831 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,746 | 51,695 | 51,684 | 51,520 | 51,335 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -162,051 | -144,374 | -118,552 | -108,385 | -103,403 |
| Other shareholders' equity | 111 | 171 | -14 | 26 | -81 |
| TOTAL | $360,487 | $374,723 | $396,312 | $402,192 | $403,078 |
| Total Liabilities And Equity | $406,629 | $422,599 | $445,501 | $454,466 | $420,909 |